Prevalence and severity of interstitial lung disease in mixed connective tissue disease: A nationwide, cross-sectional study

Annals of the Rheumatic Diseases

Volumn 71, Issue 12, 2012, Pages 1966-1972

  Gunnarsson, Ragnar ^a   Aaløkken, Trond Mogens ^a   Molberg, Øyvind ^a   Lund, May Brit ^a   Mynarek, Georg Karl ^a   Lexberg, Åse Stavland ^b   Time, Kari ^c   Dhainaut, Alvilde Sofie Strand ^d   Bertelsen, Liv Turid ^e   Palm, Øyvind ^f   Irgens, Karen ^g   Becker Merok, Andrea ^h   Nordeide, Jan Leidulf ⁱ   Johnsen, Villy ^j   Pedersen, Sonja ^k   Prøven, Anne ^l   Garabet, Lamya Samir Noori ^f   Gran, Jan Tore ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Sykehuset Buskerud HF   (Norway)

^c Haugesund Sanitetsforeningens Revmatismesykehus   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f Section for Foot and Ankle Surgery   (Norway)

^g A lesund Hospital   (Norway)

^h UNIVERSITY OF TROMSØ   (Norway)

ⁱ Section for Rheumatology   (Norway)

^j Sørlandet Hospital   (Norway)

^k NORDLAND HOSPITAL   (Norway)

^l MARTINA HANSENS HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MORTALITY; NORWAY; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MOTOR ACTIVITY; NORWAY; PREVALENCE; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX;

EID: 84868451845     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201253     Document Type: Article

References (45)

1. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
2. Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am 2005;31:411-20, v.
3. Nimelstein SH, Brody S, McShane D, et al. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980;59:239-48.
4. Sharp GC. MCTD: a concept which stood the test of time. Lupus 2002;11:333-9.
5. Swanton J, Isenberg D. Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin North Am 2005;31:421-36, v.
6. Sharp GC, Irvin WS, May CM, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976;295:1149-54.
7. Lundberg I, Nyman U, Pettersson I, et al. Clinical manifestations and anti-(U1) snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 1992;31:811-17.
8. Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63:92-107.
9. Grader-Beck T, Wigley FM. Raynaud's phenomenon in mixed connective tissue disease. Rheum Dis Clin North Am 2005;31:465-81, vi.
10. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991;18:1511-19.
11. Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999;42:899-909.
12. Gunnarsson R, Molberg O, Gilboe IM, et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis 2011;70:1047-51.
13. Bennett RM, O'Connell DJ. The arthritis of mixed connective tissue disease. Ann Rheum Dis 1978;37:397-403.
14. Oxenhandler R, Hart M, Corman L, et al. Pathology of skeletal muscle in mixed connective tissue disease. Arthritis Rheum 1977;20:985-8.
15. Coppo P, Clauvel J P, Bengoufa D, et al. Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome. Rheumatology (Oxford) 2002;41:1040-6.
16. Bonin CC, da Silva BS, Mota LM, et al. Severe and refractory myositis in mixed connective tissue disease: a description of a rare case. Lupus 2010;19:1659-61.
17. Alpert MA, Goldberg SH, Singsen BH, et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983;68:1182-93.
18. Wigley FM, Lima JA, Mayes M, et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005;52:2125-32.
19. Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124:499-503.
20. Saito Y, Terada M, Takada T, et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002;26:349-57.
21. Prakash UB. Lungs in mixed connective tissue disease. J Thorac Imaging 1992;7:55-61.
22. Kozuka T, Johkoh T, Honda O, et al. Pulmonary involvement in mixed connective tissue disease: high-resolution CT findings in 41 patients. J Thorac Imaging 2001;16:94-8.
23. Aaløkken TM, Lilleby V, Søyseth V, et al. Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol 2009;50:430-6.
24. de Lauretis A, Veeraraghavan S, Renzoni E. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 2011;8:53-82.
25. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther 2010;12:213.
26. Bennett RM, O'Connell DJ. Mixed connective tisssue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980;10:25-51.
27. Bodolay E, Szekanecz Z, Dévényi K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005;44:656-61.
28. Alarcón-Segovia D, Villarreal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier Science Publishers B V (Biomedical Division) 1987:33-40.
29. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier Science Publishers B V (Biomedical Division) 1987:41-7.
30. Sharp GC. Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC, eds. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier Science Publishers B. V. (Biomedical Division) 1987:23-30.
31. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
32. Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200:327-31.
33. Galvin JR, Frazier AA, Franks TJ. Collaborative radiologic and histopathologic assessment of fibrotic lung disease. Radiology 2010;255:692-706.
34. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Boston, Mass: Little, Brown 1994:253-6.
35. A T S Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
36. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-35.
37. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
38. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
39. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
40. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
41. McLoud TC. Role of high-resolution computed tomography in idiopathic pulmonary fibrosis: the final word? Am J Respir Crit Care Med 2005;172:408-9.
42. Sumikawa H, Johkoh T, Ichikado K, et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology 2006;241:258-66.
43. Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998;157(4 Pt 1):1063-72.
44. Khanna D, Tseng CH, Farmani N, et al. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum 2011;63:3078-85.
45. Goldin JG, Lynch DA, Strollo DC, et al. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 2008;134:358-67.